Newer Indications for ICD and CRT.

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Device Technology

Background:

• Cardiac implantable electronic device (CIED) therapy has evolved over 50 years.
• Significant advancements include implantable defibrillators (ICDs) and cardiac resynchronization therapy (CRT).
• ICDs prevent sudden cardiac death from ventricular tachyarrhythmias; CRT improves heart failure outcomes.

Purpose of the Study:

• To review current US guidelines for ICD and CRT indications.
• To highlight recent updates in CIED therapy guidelines.
• To provide a focused overview of US-specific CIED recommendations.

Main Methods:

• Literature review of current US guidelines for CIEDs.
• Analysis of recent updates in indications for ICD and CRT.
• Synthesis of guideline recommendations for clinical practice.

Main Results:

• ICDs are indicated for primary and secondary prevention of sudden cardiac death.
• CRT is indicated for specific heart failure patients to improve cardiac function.
• Recent guideline updates refine patient selection criteria for both therapies.

Conclusions:

• US guidelines provide critical direction for optimal CIED implantation.
• Adherence to updated ICD and CRT indications is essential for effective therapy.
• CIED therapy continues to be a cornerstone in managing cardiac arrhythmias and heart failure.